Boehringer Ingelheim Biopharmaceuticals (China) Ltd.

FDA-inspected organization

Boehringer Ingelheim Biopharmaceuticals (China) Ltd. has been audited by the FDA 1 times between 2023 and 2023 across all 1 sites.


Documents

FDA 483 Boehringer Ingelheim Biopharmaceuticals (China) Ltd., Shanghai | 2023

483Jun 9, 2023Shanghai / China
Out of stock

FDA Investigators (1)